Publicaciones (39) Publicaciones en las que ha participado algún/a investigador/a

2000

  1. Alpha1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 38, Núm. 1, pp. 35-40

  2. Bioadhesive potential of gliadin nanoparticulate systems

    European Journal of Pharmaceutical Sciences, Vol. 11, Núm. 4, pp. 333-341

  3. Biopolymer and polymer nanoparticles and their biomedical applications

    Handbook of Nanostructured Materials and Nanotechnology (Academic Press), pp. 577-635

  4. Characteristics and value of chromosome aberrations induced by antitumor treatments in pediatric patients with cancer

    Revista de medicina de la Universidad de Navarra, Vol. 44, Núm. 1, pp. 15-24

  5. Chemical modifications of 1,2,5-oxadiazole N-oxide system searching for cytotoxic selective hypoxic drugs

    Molecules

  6. Clinical and economic impact of a pharmacist-intervention to promote sequential intravenous to oral clindamycin conversion

    Pharmacy World and Science, Vol. 22, Núm. 2, pp. 53-58

  7. Comparative pharmacokinetics, tissue distributions, and effects on renal function of novel polymeric formulations of amphotericin B and amphotericin B-deoxycholate in rats

    Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 4, pp. 898-904

  8. Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: Application to moxonidine

    Clinical Pharmacology and Therapeutics, Vol. 68, Núm. 1, pp. 18-27

  9. Cost analysis of neuromuscular blocking agents in the operating room: Cisatracurium, atracurium, vecuronium and rocuronium

    Pharmacy World and Science, Vol. 22, Núm. 3, pp. 82-87

  10. Deontología farmacéutica: concepto y fundamento

    EUNSA. Ediciones Universidad de Navarra, S.A.

  11. Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin- 1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: Serotonin reuptake inhibition and 5-HT(1A) receptor antagonism

    Farmaco, Vol. 55, Núm. 5, pp. 345-353

  12. Determination of oligonucleotide ISIS 2922 in nanoparticulate delivery systems by capillary zone electrophoresis

    Journal of Chromatography A, Vol. 871, Núm. 1-2, pp. 311-320

  13. Development of a sensitive method for the determination of ganciclovir by reversed-phase high-performance liquid chromatography

    Journal of Chromatography A, Vol. 870, Núm. 1-2, pp. 159-167

  14. Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis

    Journal of Drug Targeting, Vol. 8, Núm. 5, pp. 289-303

  15. Efectos tóxicos de la Ocratoxína A

    Revista de toxicología, Vol. 17, Núm. 2, pp. 61-69

  16. Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer

    Therapeutic Drug Monitoring, Vol. 22, Núm. 3, pp. 250-257

  17. Efficient gene transfer by transferrin lipoplexes in the presence of serum

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1463, Núm. 2, pp. 333-342

  18. Encuesta de opinion a los pacientes sobre el medicamento en el hospital y la atencion en el servicio de farmacia

    Farmacia Hospitalaria, Vol. 24, Núm. 2, pp. 104-110

  19. Evaluation and characterisation of gliadin nanoparticles and isolates by reversed-phase HPLC

    Journal of Cereal Science, Vol. 31, Núm. 2, pp. 223-228

  20. Fundamentos de seguridad alimentaria

    Eunate